Neuropathological examination confirmed an unmethylated but isocitrate dehydrogenase 1 (IDH1) R132H-mutated glioblastoma with a high proliferation rate (MIB‐1: 15–20% immunopositive tumor cells). This evidence concerns the gene IDH1 and glioblastoma.